Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950–Metabolites in Frozen Human Plasma

John A. Bowden(National Institute of Standards and Technology), N. Alan Heckert(National Institute of Standards and Technology), Candice Z. Ulmer(National Institute of Standards and Technology), Christina M. Jones(National Institute of Standards and Technology), Jeremy P. Koelmel(University of Florida), Laila Abdullah(Roskamp Institute), Linda Ahonen(Steno Diabetes Centers), Yazen Alnouti(University of Nebraska Medical Center), Aaron M. Armando(University of California San Diego), John M. Asara(Beth Israel Deaconess Medical Center), Takeshi Bamba(Kyushu University), John R. Barr(Centers for Disease Control and Prevention), Jonas Bergquist(Uppsala University), Christoph H. Borchers(University of Victoria), Joost Brandsma(Southampton General Hospital), Susanne B. Breitkopf(Beth Israel Deaconess Medical Center), Tomáš Čajka(National Institutes of Health), Amaury Cazenave‐Gassiot(National University of Singapore), Antonio Checa(Karolinska Institutet), Michelle Cinel(Baker Heart and Diabetes Institute), Romain A. Colas(Brigham and Women's Hospital), Serge Cremers(Columbia University Irving Medical Center), Edward A. Dennis(University of California San Diego), James E. Evans(Roskamp Institute), Alexander Fauland(Karolinska Institutet), Oliver Fiehn(National Institutes of Health), Michael S. Gardner(Centers for Disease Control and Prevention), Timothy J. Garrett(University of Florida), Katherine Gotlinger(New York Medical College), Jun Han(University of Victoria), Yingying Huang(Thermo Fisher Scientific (United States)), Aveline Huipeng Neo(National University of Singapore), Tuulia Hyötyläinen(Örebro University), Yoshihiro Izumi(Kyushu University), Hongfeng Jiang(New York Medical College), Houli Jiang(New York Medical College), Jiang Jiang(University of California San Diego), Maureen Kachman(University of Michigan), Reiko Kiyonami(Thermo Fisher Scientific (United States)), Kristaps Klavins(Biocrates Life Sciences (Austria)), Christian Klose, Harald Köfeler(Medical University of Graz), Johan Kolmert(Karolinska Institutet), Therese Koal(Biocrates Life Sciences (Austria)), Grielof Koster(Southampton General Hospital), Zsuzsanna Kuklenyik(Centers for Disease Control and Prevention), Irwin J. Kurland(Albert Einstein College of Medicine), Michael Leadley(Hospital for Sick Children), Karen Lin(University of Victoria), Krishna Rao Maddipati(Wayne State University), Danielle McDougall(University of Florida), Peter J. Meikle(Baker Heart and Diabetes Institute), Natalie A. Mellett(Baker Heart and Diabetes Institute), Cian Monnin(Concordia University), M. Arthur Moseley(Duke University), Renu Nandakumar(Columbia University Irving Medical Center), Matej Orešič(Åbo Akademi University), R. E. Patterson(University of Florida), David A. Peake(Thermo Fisher Scientific (United States)), Jason S. Pierce(Medical University of South Carolina), Martin Post(Hospital for Sick Children), Anthony D. Postle(Southampton General Hospital), Rebecca S. Pugh(National Institute of Standards and Technology), Yunping Qiu(Albert Einstein College of Medicine), Oswald Quehenberger(University of California San Diego), Parsram Ramrup(Concordia University), Jon C. Rees(Centers for Disease Control and Prevention), Barbara Rembiesa(Medical University of South Carolina), Dénis Reynaud(Hospital for Sick Children), Mary R. Roth(Kansas State University), Susanne Sales(Max Planck Institute of Molecular Cell Biology and Genetics), Kai Schuhmann(Max Planck Institute of Molecular Cell Biology and Genetics), Michal L. Schwartzman(New York Medical College), Charles N. Serhan(Brigham and Women's Hospital), Andrej Shevchenko(Max Planck Institute of Molecular Cell Biology and Genetics), Stephen E. Somerville(Medical University of South Carolina), Lisa St. John‐Williams(Duke University), Michał A. Surma, Hiroaki Takeda(Kyushu University), Rhishikesh Thakare(University of Nebraska Medical Center), J. Will Thompson(Duke University), Federico Torta(National University of Singapore), Alexander Triebl(Medical University of Graz), Martin Trötzmüller(Medical University of Graz), S. J. Kumari A. Ubhayasekera(Uppsala University), Dajana Vuckovic(Concordia University), Jacquelyn M. Weir(Baker Heart and Diabetes Institute), Ruth Welti(Kansas State University), Markus R. Wenk(National University of Singapore), Craig E. Wheelock(Karolinska Institutet), Libin Yao(Kansas State University), Min Yuan(Beth Israel Deaconess Medical Center), Xueqing Zhao(Albert Einstein College of Medicine), Sen-Lin Zhou(Wayne State University)
Journal of Lipid Research
October 7, 2017
Cited by 408Open Access
Full Text

Abstract

As the lipidomics field continues to advance, self-evaluation within the community is critical. Here, we performed an interlaboratory comparison exercise for lipidomics using Standard Reference Material (SRM) 1950-Metabolites in Frozen Human Plasma, a commercially available reference material. The interlaboratory study comprised 31 diverse laboratories, with each laboratory using a different lipidomics workflow. A total of 1,527 unique lipids were measured across all laboratories and consensus location estimates and associated uncertainties were determined for 339 of these lipids measured at the sum composition level by five or more participating laboratories. These evaluated lipids detected in SRM 1950 serve as community-wide benchmarks for intra- and interlaboratory quality control and method validation. These analyses were performed using nonstandardized laboratory-independent workflows. The consensus locations were also compared with a previous examination of SRM 1950 by the LIPID MAPS consortium. While the central theme of the interlaboratory study was to provide values to help harmonize lipids, lipid mediators, and precursor measurements across the community, it was also initiated to stimulate a discussion regarding areas in need of improvement.


Related Papers

No related papers found

Powered by citation graph analysis